Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Demyelination and other neurological adverse events after anti-TNF therapy.
Assessment of system dysfunction in the brain through MRI-based connectomics.
Chronic deep brain stimulation for the treatment of tremor in multiple sclerosis: review and case reports.
Autoimmune disease prevalence in a multiple sclerosis cohort in Argentina.
Does Disease-Irrelevant Intrathecal Synthesis in Multiple Sclerosis Make Sense in the Light of Tertiary Lymphoid Organs?
Walking capacity and ability are more impaired in progressive compared to relapsing type of multiple sclerosis.
Thymic peptides restrain the inflammatory response in mice with experimental autoimmune encephalomyelitis.
Dalfampridine: A Medication to Improve Walking in Patients with Multiple Sclerosis (July/August).
Symptomatic correlates of six-minute walk performance in persons with multiple sclerosis.
Visual resting-state network in relapsing-remitting MS with and without previous optic neuritis.
Search for cellular stress biomarkers in lymphocytes from patients with multiple sclerosis: a pilot study.
Cost Effectiveness of Oromucosal Cannabis-Based Medicine (Sativex®) for Spasticity in Multiple Sclerosis.
Management of faecal incontinence and constipation in adults with central neurological diseases.
Human Mesenchymal Stem Cells Upregulate CD1dCD5(+) Regulatory B Cells in Experimental Autoimmune Encephalomyelitis.
Preventive and Therapeutic Effects of Adenanthin on Experimental Autoimmune Encephalomyelitis by Inhibiting NF-κB Signaling.
Chromosomal radiosensitivity in patients with multiple sclerosis.
Update on multiple sclerosis treatments.
An anomalous case of acute coronary syndrome: the unexpected autoimmune duo.
Opioid growth factor arrests the progression of clinical disease and spinal cord pathology in established experimental autoimmune encephalomyelitis.
TCR Bias and HLA Cross-Restriction Are Strategies of Human Brain-Infiltrating JC Virus-Specific CD4+ T Cells during Viral Infection.
Supporting work for people with multiple sclerosis.
Application of laser radiation and magnetostimulation in therapy of patients with multiple sclerosis.
Intracellular signaling pathway regulation of myelination and remyelination in the CNS.
Liver X Receptors differentially modulate central myelin gene mRNA levels in a region-, age- and isoform-specific manner.
The association between olfactory bulb volume, cognitive dysfunction, physical disability and depression in multiple sclerosis.
Pages
« first
‹ previous
…
313
314
315
316
317
318
319
320
321
…
next ›
last »